Search Results 281-290 of 17554 for what is vedolizumab

  1. The role of capsule endoscopy in diagnosis and management of inflammatory bowel disease - Mayo Clinic

    Small bowel CE provides us with a well-tolerated, less invasive way to visualize the entire length of the small bowel in patients with Crohn's disease (CD). In ...

  2. Mesalamine dose may lower marker of bowel inflammation Videos - Mayo Clinic

    A lower level of calprotectin is associated with a lower risk of having an ulcerative colitis flare. In inflammatory bowel disease (IBD), there can be a ...

  3. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

    Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to ...

  4. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

    The purpose of this extension study is to monitor the safety and effectiveness of etrolizumab treatment in patients with moderate to severely active Crohn's ...

  5. IBD Biobank Study

    Mayo Clinic's IBD Biobank Study collects biological samples & medical information to advance research on inflammatory bowel disease, Crohn's disease & other ...

  6. Expert explains how inflammatory bowel disease, irritable bowel syndrome differ - Mayo Clinic News Network

    Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease. In inflammatory bowel disease, the immune ...

  7. Mayo Clinic Minute: What is inflammatory bowel disease? Video Audio People often associate inflammatory bowel disease with t

    "Ulcerative colitis only impacts the colon and causes inflammation in the entire colon, while. Crohn's disease can impact anywhere from the mouth to the ...

  8. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo ...

  9. Crohn's disease is an inflammatory bowel disease - Mayo Clinic News Network

    Crohn's disease causes inflammation of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition.

  10. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.